PMID- 38150850
OWN - NLM
STAT- MEDLINE
DCOM- 20240428
LR  - 20240502
IS  - 1578-1275 (Electronic)
IS  - 0212-6567 (Print)
IS  - 0212-6567 (Linking)
VI  - 56
IP  - 5
DP  - 2024 May
TI  - [New tools for medication review: DRP in patients treatment with proton pump 
      inhibitors].
PG  - 102836
LID - S0212-6567(23)00269-X [pii]
LID - 10.1016/j.aprim.2023.102836 [doi]
LID - 102836
AB  - OBJECTIVE: To analyze, using the medication review program, Revisem(R), the 
      prevalence of drug-related problems (DRP) in patients in the province of Valencia 
      who were on active treatment with proton pump inhibitors (PPI) in 2022. DESIGN: 
      Descriptive and retrospective observational study. MATERIAL AND METHODS: The 
      pharmacotherapeutic history of 295 patients was analyzed following the criteria 
      proposed by the Pharmaceutical Care Network Europe, using the Revisem(R) digital 
      platform of the Muy Ilustre Colegio Oficial de Farmaceuticos (MICOF). RESULTS: 
      The mean age of the patients was 81.8 +/- 11.1 years and 66.4% were women. At least 
      one DRP was detected in 97.3% of patients. 46.9% of the DRP analyzed were 
      interactions, of which 29.7% involved a PPI, with omeprazole being the most 
      frequent. DRPs with PPI are significantly related to certain patient conditions 
      and pharmacological groups, such as female sex, age over 54 years and 
      polypharmacy. CONCLUSIONS: The application of the Revisem(R) digital platform 
      allows the detection of a high prevalence of DRP at the provincial level. The 
      application of new technological tools to detect the prevalence of DRP is 
      essential to optimize patient treatments.
CI  - Copyright (c) 2023 The Authors. Publicado por Elsevier Espana S.L.U. All rights 
      reserved.
FAU - Gutierrez-Igual, Salvador
AU  - Gutierrez-Igual S
AD  - Servicios Asistenciales Farmaceuticos y Formacion, Muy Ilustre Colegio Oficial de 
      Farmaceuticos de Valencia (MICOF), Valencia, Espana; Departamento de 
      Farmacologia, Universidad de Valencia (UV), Burjassot, Espana. Electronic 
      address: salvador.gutierrez@micof.es.
FAU - Lucas-Dominguez, Rut
AU  - Lucas-Dominguez R
AD  - UISYS, Departamento de Historia de la Ciencia y Documentacion, Facultad de 
      Medicina y Odontologia, Universidad de Valencia (UV), Valencia, Espana; Unidad 
      asociada al Instituto Interuniversitario de Investigacion Avanzada sobre 
      Evaluacion de la Ciencia y la Universidad (INAECU), UC3M-UAM3, Madrid, Espana; 
      CIBERONC, Valencia, Espana. Electronic address: rut.lucas@uv.es.
FAU - Marti Rodrigo, Alberto
AU  - Marti Rodrigo A
AD  - Servicios Asistenciales Farmaceuticos y Formacion, Muy Ilustre Colegio Oficial de 
      Farmaceuticos de Valencia (MICOF), Valencia, Espana.
FAU - Romero Crespo, Isabel
AU  - Romero Crespo I
AD  - Servicios Asistenciales Farmaceuticos y Formacion, Muy Ilustre Colegio Oficial de 
      Farmaceuticos de Valencia (MICOF), Valencia, Espana.
FAU - Montesinos Mezquita, M Carmen
AU  - Montesinos Mezquita MC
AD  - Departamento de Farmacologia, Universidad de Valencia (UV), Burjassot, Espana; 
      Equipo Estudios de Bioactividad, Instituto Interuniversitario de Reconocimiento 
      Molecular y Desarrollo Tecnologico (IDM). Universidad Politecnica de Valencia 
      (UPV). Universidad de Valencia (UV), Valencia, Espana.
LA  - spa
PT  - English Abstract
PT  - Journal Article
PT  - Observational Study
TT  - Nuevas herramientas para la revision de la medicacion: PRM en pacientes en 
      tratamiento con inhibidores de la bomba de protones.
DEP - 20231226
PL  - Spain
TA  - Aten Primaria
JT  - Atencion primaria
JID - 9111075
RN  - 0 (Proton Pump Inhibitors)
SB  - IM
MH  - Humans
MH  - *Proton Pump Inhibitors/therapeutic use
MH  - Female
MH  - Male
MH  - Retrospective Studies
MH  - Aged, 80 and over
MH  - Aged
MH  - Middle Aged
MH  - Drug-Related Side Effects and Adverse Reactions/epidemiology
PMC - PMC11058877
OTO - NOTNLM
OT  - Community pharmacy
OT  - Drug Related Problem
OT  - Farmacia comunitaria
OT  - Inhibidor de la bomba de protones
OT  - Omeprazol
OT  - Omeprazole
OT  - Plataforma digital Revisem(R)
OT  - Problema relacionado con la medicacion
OT  - Proton Pump Inhibitor
OT  - Revisem(R) digital platform
EDAT- 2023/12/28 00:42
MHDA- 2024/04/29 01:00
PMCR- 2023/12/26
CRDT- 2023/12/27 18:06
PHST- 2023/10/16 00:00 [received]
PHST- 2023/11/09 00:00 [revised]
PHST- 2023/11/13 00:00 [accepted]
PHST- 2024/04/29 01:00 [medline]
PHST- 2023/12/28 00:42 [pubmed]
PHST- 2023/12/27 18:06 [entrez]
PHST- 2023/12/26 00:00 [pmc-release]
AID - S0212-6567(23)00269-X [pii]
AID - 102836 [pii]
AID - 10.1016/j.aprim.2023.102836 [doi]
PST - ppublish
SO  - Aten Primaria. 2024 May;56(5):102836. doi: 10.1016/j.aprim.2023.102836. Epub 2023 
      Dec 26.